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Dr. Moji Ukabi 
COVID Vaccine Hesitancy
• According to the latest KFF COVID-19 Vaccine Monitor, since December 2020: 1,6 
• Increase of individuals receiving COVID-19 vaccine or planning to (estimated 61%) 
• Decrease of individuals using the “wait and see” approach (now 17%), 
• Same number of individuals who are not going to get vaccinated (13%)
• Largest increase of Black adults (55% are vaccinated or going to get the vaccination) 
• one-quarter of them are using the “wait and see” approach 
• One in five adults living in rural areas will not get vaccinated 
• The KFF COVID-19 Vaccine Monitor stated they will be testing “if potential incentives, messages, and pieces of information” may influence more individuals to get 
vaccinated1,6 
• Vaccination sites occurring in medical settings and clinics
• Requirements to get vaccinated in order to travel freely and not wear a masks
• Employers providing incentives like cash bonuses and on-site vaccination 
• These statistics show there is an increase of individuals getting vaccinated, and a decrease of individuals who are waiting to see before making a decision to get 
vaccinated . The data also shows that those individuals who are using the “wait and see” approach would benefit from incentives from their employers as well as 
the convenience of getting vaccinated at their medical provider’s office.
• We need to continue engaging in conversations about the vaccine along with providing incentives for those uncertain about vaccinations. 
Public Health Costs of Covid Vaccine 
• The Centers for Disease Control and Prevention (CDC) released a statement stating they would provide 
funds that support communities to increase vaccination by: 3 
• Increasing COVID-19 vaccine programs and providing more access to the vaccines 
• Funding $250 million to community-based organizations that serve minority or underserved 
communities to support their COVID-19 outreach efforts, including connecting members of the 
community with health services and vaccinations.
• HHS Office of Minority Health is also investing $250 million to encourage COVID-19 safety and 
vaccination among underserved populations in minority communities.
• According to CDC, they may invest $2.25 billion to “address COVID-19-related health disparities” and may 
invest $300 million to “jurisdictions for community health worker services to support COVID-19 
prevention and control and address disparities in access to COVID-19 related services.” 3 
Community Perspective
• This project is a continuation from the original 
project titled, “Addressing COVID-19 Vaccine 
Hesitancy” that was conducted in January 2021
• Two interviews were conducted with healthcare 
providers about patients’ opinions about receiving 
the COVID-19 vaccines 
• Healthcare professionals noticed that more patients are 
getting vaccinated, but many are still unsure if they want to 
get vaccinated and worry about the side effects. 
• Health care professionals provide education about COVID-19. 
They provide their knowledge, expertise, and guidance about 
the COVID-19 vaccines. They address the concerns of their 
patients and encourage them to receive the vaccine, but also 
respect their decision if they decline. 
• More importantly healthcare professionals provide an open 
space for individuals to express their belief and hesitancy. 
• Concerns from the patients:
• Some patients still seem wary of the 
development of the vaccine
• Recent Johnson & Johnson recall 
concerned patients 
• Patients are unsure to finish their vaccine 
dosage, if they get adverse reaction from 
their first dosage 
• Patients are scheduling appointments to 
converse about their COVID-19 symptoms 
if they contracted it. 
• Patients want to know if they can get  
other vaccines once they receive at least 
their first dose of the COVID-19 vaccines 
Intervention and Methodology 
Methodology: 
• Provide an educational handout explaining what is the disease COVID-19, how does it work, efficacy, safety  
• Provide doctor’s perspective and knowledge about COVID-19 and development of the vaccine
• Ask patients if they have or plan to receive a COVID-19 vaccine
• Provide a safe and open space to allow the patient to ask questions or concerns as well explain the importance of 
getting the vaccine.
Intervention: 
• The goal is to engage in conversations to understand people’s views and reasons to receive or not receive the vaccine in 
the community  
• This intervention is categorized under the AHEC Scholars Core Topic: Current and Emerging Health Issues
Results/Responses 
Total Survey Responses: 21 
Demographics:
• Age  – 48% were 55+, 33% were 45-54, 19% 25-34
• Race – 95% White
• Education – 33% Graduate/Professional, 24% high school, 29% 
college, 14% some college, 6% college   
COVID- 19 related questions:
• 71% have not contracted COVID-19 
• 52% of patients strongly agree that if a vaccine is recommended for 
them, they will get it.
• Top three sources that patients receive information about COVID-19: 
• Television, healthcare professionals, health officials 
• 71% have received both doses of the COVID-19 vaccine 
Handout related results:
• 81% of people answered yes to “after 
reading the handout, do you feel that you 
have a better understanding on how a 
vaccine works?”
• 81% of people answered yes to “after 
reading the handout, do you believe the 
vaccine is effective?”
• 53% of people answered yes to “after 
reading the handout, do you feel safer to the 




• Provided surveys to assess whether a patient’s hesitancy to get vaccinated has changed or whether 
they are more willing to receive a vaccine 
• Effectiveness:
• For those who took the survey, they felt comfortable to ask about side effects, effectiveness, and 
when they should take other vaccines
• For those who did not take the quiz, some engaged in conversations about the vaccine and asked for 
advice and guidance. 
• Limitations:
• Sample size
• Survey was only provided in English which prevented some individuals of taking the survey 
Recommendations for Future Projects 
• Although there are resources about COVID-19 and the vaccines, patients want to engage in conversation 
about the virus and vaccine with their health providers. 
• Patients, especially those who received the vaccine, are uncertain about the side effects and why individuals 
react differently to the vaccine.
• Patients are curious about the development of the vaccine. 
• Patients with long lasting effects due to contracting COVID-19 do not know that their programs and treatment 
to help them with their symptoms.  
Observations: 
• To assess if people understand what a vaccine does to our body and why we get an immune reaction
• Determine which patients may benefit from the COVID Recovery Vaccine Program and create a handout to 
educate them about these services
• Determine which patients may be eligible to receive the COVID-19 monoclonal antibody infusion
Recommendations for future interventions/projects: 
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• Thank you for agreeing to be interviewed. This 
project is a requirement for the Family Medicine 
clerkship. It will be stored on the Dana Library 
ScholarWorks website. Your name will be 
attached to your interview and you may be cited 
directly or indirectly in subsequent unpublished 
or published work. The interviewer affirms that 
he/she has explained the nature and purpose of 
this project. The interviewee affirms that he/she 
has consented to this interview. 
